A detailed history of Srs Capital Advisors, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 196 shares of DXCM stock, worth $12,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares
196
Holding current value
$12,936
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$110.31 - $140.45 $21,620 - $27,528
196 New
196 $22,000
Q3 2022

Nov 03, 2022

SELL
$76.35 - $94.18 $610 - $753
-8 Closed
0 $0
Q2 2022

Aug 22, 2022

BUY
$67.99 - $132.89 $407 - $797
6 Added 300.0%
8 $1,000
Q3 2021

Nov 05, 2021

BUY
$106.71 - $143.18 $213 - $286
2 New
2 $1,000
Q2 2021

Aug 02, 2021

SELL
$80.99 - $107.93 $323 - $431
-4 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$78.0 - $104.5 $312 - $418
4 New
4 $1,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.